Menu
05/01/09   |   By

Stalled Suits Against Drug Companies Now Proceeding | DC Metro Area Medical Malpractice Law Blog

5 stars

Posted by Patrick Regan and Paul Cornoni

Bloomberg News (4/30 Fisk, Feeley) reports, “Just two months after the U.S. Supreme Court decided patients can sue drugmakers over injuries from medicines approved by the government, long-stalled lawsuits against GlaxoSmithKline Plc and Bristol-Myers Squibb Co. are again moving toward trials.”

The Supreme Court’s decision in Wyeth essentially states that federal regulatory approval (FDA) of a medicine or drug doesn’t shield drugmakers from claims that patients were not adequately warned of potential side effects and other harms.  The Wyeth decision has already affected more than 250 lawsuits involving at least ten different drug companies.

As the article explains: “Glaxo this month settled two cases on claims its antidepressant Paxil can make patients suicidal, after judges set trials citing the Wyeth decision. A Barr Pharmaceuticals hyperactivity-drug case is to be tried in August in federal court in Tallahassee, Florida. And a group of Bristol-Myers lawsuits over the blood-thinner Plavix may now proceed to trial in federal court in Trenton, New Jersey.”

Regan Zambri Long
Posted In
Uncategorized
Share This Article

Frequently Asked Questions

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Back to Top